HOLD

• Price trading above 50 SMA at 67.90 (price 68.72) — medium-term structure intact, not a breakdown
• MACD histogram moved 34 basis points from +0.32 to -0.02 over 17 bars — indicator at 0.39 vs signal 0.41, two-cent difference is noise not reversal
• RSI at 52 means neutral, not overbought or a sell signal — aggressive analyst reads indicator backwards
• 1.28x FCF dividend coverage is tight by design, not fragile — Altria maintained and raised dividend through 2008 recession, FDA actions, and litigation cycles including Q4 2025 $1.26B NJOY write-down
• Buyback cut at 14.5x trailing P/E with 6.4% dividend yield is rational capital allocation, not fearful —不舍得 destroying shareholder value with overpriced repurchases
• Bollinger Band squeeze has no directional bias per technical report — breakout resolves either to 70.40-74 or below 66.90 to test 200 SMA at 65.24
• Trim forfeits 6.4% yield (quarterly $1.06-$1.11/share) plus potential capital gains taxes (25-40% of trim) with re-entry risk if stock breaks upward through squeeze
• 30-year UST at 2002 highs is real headwind but 6.4% MO yield still significantly exceeds 10-year; UK recession probabilities rose 5.5 percentage points in one week, supporting eventual long-end yield decline
• NJOY PMTA risks already absorbed via $1.26B write-down — market expectations reset, adverse outcome unlikely to be fundamental surprise
• Stop loss at $64.50 (below 200 SMA at $65.24) is disciplined risk management; triggers only if price closes below $66.90 on volume — wait for range break signal rather than predicting direction

→ vs aggressive: 50 SMA rollover from 70.41 to 67.90 is not a 3.6% medium-term trend reversal — with beta 0.494, this is normal defensive drift, and price still above 50 SMA means structure intact

→ vs aggressive: MACD deterioration claim overstates a 34 basis point histogram move on an absolute-dollar indicator as structural breakdown when it's two cents off the signal line

→ vs aggressive: RSI at 52 is neutral territory, not a level where stock hands back gains — calling it a sell signal is reading the indicator backwards

→ vs aggressive: 1.28x FCF coverage is adequate by design; calling dividend fragile ignores consistent payments through every recession and FDA action cycle including the Q4 2025 write-down

→ vs aggressive: Buyback cut reflects good capital allocation at 14.5x P/E when dividend yields 6.4% — aggressive interpretation of 'management scared' is backward

→ vs aggressive: Bollinger Band squeeze has no directional bias per the technical report itself — claiming probabilities favor downside relies on narrative, not probability

→ vs aggressive: Trim forfeits meaningful yield capture, triggers potential capital gains taxes (25-40%), and creates asymmetric re-entry risk if MO breaks upward through squeeze to $73-74

→ vs aggressive: Treating NJOY PMTA as unpriced binary is wrong — $1.26B write-down already reset expectations; 32% Fre prediction market is thin-liquidity retail flow, not institutional positioning

Trim 15-20% of position, retain hard stop at 64.50, add mental warning level at 66.90

• 50 SMA rolling from 70.41 to 67.90 represents 3.6% drift over two months on stock with beta of 0.494; medium-term trend has softened
• Upper Bollinger Band at 70.40 is only 2.4% upside from current 68.72 entry; lower band at 66.90
• Stop loss at 64.50 represents 6.1% downside, creating roughly 2-to-1 risk-reward against on tactical basis
• MACD is negative after 17 bars of deterioration, two cents below signal line
• Polymarket data shows 96% probability of zero Fed cuts in 2026, signaling persistent restrictive policy
• 10-year competing with MO's 6.4% yield on tax-equivalent basis creates real yield compression
• NJOY PMTA is binary 'can product stay on shelves' event—impairment taken does not equal resolved regulatory risk
• 30-day catalyst watchlist includes NJOY PMTA, Q3 earnings, and potential pouch M&A announcements; any catalyst can move stock 3-5%
• Dividend coverage at 1.28x is adequate in base case but vulnerable in tail scenario
• Trim should be sized to absorb one adverse catalyst rather than pre-committing to full technical exit
• Conservative's buyback cut at 14.5x earnings with dividend yield exceeding cost of equity is rational capital allocation, not fear signal

→ vs aggressive: Cites MACD two cents below signal and 50 SMA sloping down as 'probabilities favor downside' but technical report says squeeze is directionally neutral—call this motivated reasoning rather than probability analysis

→ vs aggressive: Benchmark target of 75% consumer staples weight ignores overall portfolio construction; should be calibrated to total portfolio exposure, not MO in isolation

→ vs conservative: 30-year at 2002 highs with rising UK recession probabilities (5.5pp) is backward-looking; Polymarket 96% zero-cuts probability means market pricing persistent restrictive policy, not imminent easing

→ vs conservative: Stop at 64.50 requires giving back $4.20 per share before activating—calling this 'discipline' obscures that it's a stop wide enough to absorb meaningful capital loss

→ vs conservative: Dismissal of momentum exhaustion and sign flip after 17 bars of deterioration is treating a close below 64.50 as 'confirmation' that's already cost $4 per share